"Streptococcus pneumoniae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
| Descriptor ID |
D013296
|
| MeSH Number(s) |
B03.353.750.737.872.550 B03.510.400.800.872.550 B03.510.550.737.872.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptococcus pneumoniae".
Below are MeSH descriptors whose meaning is more specific than "Streptococcus pneumoniae".
This graph shows the total number of publications written about "Streptococcus pneumoniae" by people in this website by year, and whether "Streptococcus pneumoniae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 10 | 2 | 12 |
| 1996 | 6 | 1 | 7 |
| 1997 | 5 | 1 | 6 |
| 1998 | 6 | 3 | 9 |
| 1999 | 5 | 0 | 5 |
| 2000 | 5 | 3 | 8 |
| 2001 | 8 | 4 | 12 |
| 2002 | 6 | 3 | 9 |
| 2003 | 3 | 5 | 8 |
| 2004 | 4 | 3 | 7 |
| 2005 | 3 | 2 | 5 |
| 2006 | 6 | 3 | 9 |
| 2007 | 4 | 1 | 5 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 5 | 3 | 8 |
| 2011 | 8 | 4 | 12 |
| 2012 | 7 | 0 | 7 |
| 2013 | 2 | 2 | 4 |
| 2014 | 3 | 1 | 4 |
| 2015 | 4 | 1 | 5 |
| 2016 | 8 | 2 | 10 |
| 2017 | 5 | 2 | 7 |
| 2018 | 4 | 3 | 7 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 2 | 3 |
| 2021 | 2 | 3 | 5 |
| 2022 | 1 | 3 | 4 |
| 2023 | 2 | 2 | 4 |
| 2024 | 1 | 1 | 2 |
| 2025 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptococcus pneumoniae" by people in Profiles.
-
Amoxicillin vs. ceftriaxone to treat pneumonia caused by amoxicillin-non-susceptible Streptococcus pneumoniae. Antimicrob Agents Chemother. 2025 Sep 03; 69(9):e0078025.
-
Urinary pneumococcal serotype detection among children with and without community-acquired pneumonia. BMC Infect Dis. 2025 Aug 07; 25(1):995.
-
Pneumococcal colonization dynamics among young children with and without respiratory symptoms during the first year of the SARS-CoV-2 pandemic. PLoS One. 2025; 20(6):e0327046.
-
Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis. Pediatr Infect Dis J. 2025 Apr 21; 44(7):622-629.
-
The Microbiology and Clinical Presentation of Acute Bacterial Arthritis in Houston Area Children <5 Years Old in the Era of Molecular Diagnostics. Pediatr Infect Dis J. 2025 Mar 21; 44(8):735-741.
-
Pneumococcal Colonization in Children With Persistent Asthma: A Retrospective Cohort. Pediatr Infect Dis J. 2024 Nov 01; 43(11):1033-1039.
-
Neighborhood-level disadvantages increase risk for invasive pneumococcal disease. Am J Med Sci. 2024 05; 367(5):304-309.
-
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):137-147.
-
Development and validation of a multiplex real-time PCR assay for detection and quantification of Streptococcus pneumoniae in pediatric respiratory samples. Microbiol Spectr. 2023 Dec 12; 11(6):e0211823.
-
Development and performance of a multiplex PCR assay for the?detection of bacteria in sterile body fluids. Future Microbiol. 2023 02; 18:187-195.